O
OKYO Pharma Ltd
NASDAQ:OKYO
OKYO Pharma Ltd
NASDAQ:OKYO
Price:
1.71
USD
0.59%
Market Cap:
$65.7m
Balance Sheet
Balance Sheet Decomposition
OKYO Pharma Ltd
OKYO Pharma Ltd
Balance Sheet Decomposition is not available for
OKYO Pharma Ltd
OKYO Pharma Ltd
Balance Sheet
OKYO Pharma Ltd
OKYO Pharma Ltd
Currency: GBP
| Mar-2020 | Mar-2021 | Mar-2022 | ||
|---|---|---|---|---|
| Assets | ||||
| Cash & Cash Equivalents |
0
|
5
|
2
|
|
| Cash Equivalents |
0
|
5
|
2
|
|
| Total Receivables |
0
|
0
|
1
|
|
| Accounts Receivables |
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
1
|
|
| Other Current Assets |
0
|
0
|
1
|
|
| Total Current Assets |
0
|
5
|
3
|
|
| PP&E Net |
0
|
0
|
0
|
|
| PP&E Gross |
0
|
0
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
|
| Total Assets |
0
N/A
|
5
+964%
|
3
-36%
|
|
| Liabilities | ||||
| Accounts Payable |
0
|
0
|
1
|
|
| Accrued Liabilities |
0
|
1
|
0
|
|
| Short-Term Debt |
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
|
| Total Current Liabilities |
1
|
1
|
1
|
|
| Long-Term Debt |
0
|
0
|
0
|
|
| Total Liabilities |
1
N/A
|
1
+115%
|
1
-20%
|
|
| Equity | ||||
| Common Stock |
68
|
67
|
77
|
|
| Retained Earnings |
68
|
63
|
75
|
|
| Other Equity |
0
|
0
|
0
|
|
| Total Equity |
0
N/A
|
4
N/A
|
2
-42%
|
|
| Total Liabilities & Equity |
0
N/A
|
5
+964%
|
3
-36%
|
|
| Shares Outstanding | ||||
| Common Shares Outstanding |
0
|
0
|
0
|
|
Switch to:
Switch to:
See Also
Discover More
